Pajjiż: Svizzera
Lingwa: Ġermaniż
Sors: Swissmedic (Swiss Agency for Therapeutic Products)
xylometazolini hydrochloridum
Spirig HealthCare AG
R01AA07
xylometazolini hydrochloridum
Nasenspray
xylometazolini hydrochloridum 1 mg/ml corresp. xylometazolini hydrochloridum 90 µg pro dosi, kalii dihydrogenophosphas, aqua maris, aqua purificata ad solutionem pro 1 ml, doses pro vase 100.
D
Synthetika
Nasenschleimhautentzündung
zugelassen
1970-01-01